Evidence map›Paper›PMID 37175327›Full record

ArticleMolecules (Basel, Switzerland)2023

Three Component One-Pot Synthesis and Antiproliferative Activity of New [1,2,4]Triazolo[4,3-

Manel Ben Hassen, Dhouha Msalbi, Badr Jismy, Fares Elghali, Sami Aifa, Hassan Allouchi, Mohamed Abarbri, Fakher Chabchoub

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Manel Ben HassenLaboratory of Applied Chemistry: Heterocycles, Lipids, and Polymers, Faculty of Sciences of Sfax, University of Sfax, Sfax 3000, Tunisia.
Dhouha MsalbiLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax 3018, Tunisia.
Badr JismyLaboratory of Physico-Chemistry of Materials and Electrolytes for Energy (PCM2E), Faculty of Science and Technology, University of Tours, 37200 Tours, France.ORCID 0000-0003-1553-0189
Fares ElghaliLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax 3018, Tunisia.ORCID 0000-0002-8793-138X
Sami AifaLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax 3018, Tunisia.ORCID 0000-0003-1466-5890
Hassan AllouchiFaculty of Pharmacy, University of Tours, 37200 Tours, France.
Mohamed AbarbriLaboratory of Physico-Chemistry of Materials and Electrolytes for Energy (PCM2E), Faculty of Science and Technology, University of Tours, 37200 Tours, France.ORCID 0000-0002-6742-1075
Fakher ChabchoubLaboratory of Applied Chemistry: Heterocycles, Lipids, and Polymers, Faculty of Sciences of Sfax, University of Sfax, Sfax 3000, Tunisia.ORCID 0000-0003-4375-0277

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of new [1,2,4]triazolo[4,3-a]pyrimidine derivatives was prepared using a one-pot three-component synthesis from 5-amino-1-phenyl-1

Indexed as

Antineoplastic AgentsPyrimidinesCell Line, TumorCell ProliferationCisplatinDrug Screening Assays, AntitumorHumansMagnetic Resonance SpectroscopyMCF-7 CellsMolecular StructureStructure-Activity RelationshipAntineoplastic AgentsCisplatinPyrimidinesantitumoralbreast cancermulticomponent reactionone-pot reactiontriazolopyrimidine

Identifiers

PMID37175327
PMCPMC10180348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.